Recurrence of high-grade cervical abnormalities following conservative management of cervical intraepithelial neoplasia grade 2

May 6, 2017 by in GYNECOLOGY Comments Off on Recurrence of high-grade cervical abnormalities following conservative management of cervical intraepithelial neoplasia grade 2

Objective Conservative management of cervical intraepithelial neoplasia (CIN) grade 2 in women younger than 25 years may reduce overtreatment. However, long-term efficacy remains uncertain. This retrospective cohort study aimed to…

read more

Mobile application for information on reversible contraception: a randomized controlled trial

May 6, 2017 by in GYNECOLOGY Comments Off on Mobile application for information on reversible contraception: a randomized controlled trial

Objective Due to time constraints that limit physician’s ability to deliver detailed contraception counseling, patients increasingly require supplemental education opportunities. Applications for smartphones and tablets are being designed to educate…

read more

Subtotal versus total abdominal hysterectomy: randomized clinical trial with 14-year questionnaire follow-up

May 6, 2017 by in GYNECOLOGY Comments Off on Subtotal versus total abdominal hysterectomy: randomized clinical trial with 14-year questionnaire follow-up

Materials and Methods In 1996–2000, 319 women from 11 gynecological departments in Denmark were randomized to SAH vs TAH. Details about eligibility criteria, consent, inclusion, randomization, and surgical procedures have…

read more

Cost-utility comparison of neoadjuvant chemotherapy versus primary debulking surgery for treatment of advanced-stage ovarian cancer in patients 65 years old or older

May 6, 2017 by in GYNECOLOGY Comments Off on Cost-utility comparison of neoadjuvant chemotherapy versus primary debulking surgery for treatment of advanced-stage ovarian cancer in patients 65 years old or older

Objective Treatment for advanced-stage epithelial ovarian cancer (AEOC) includes primary debulking surgery (PDS) or neoadjuvant chemotherapy (NACT). A randomized controlled trial comparing these treatments resulted in comparable overall survival (OS)….

read more
Get Clinical Tree app for offline access